FBR & Co. Reports Fourth Quarter 2016 Pre-Tax Income of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
69
FBR & Co. Reports Fourth Quarter 2016 Pre-Tax Income of $5.2 Million on Net Revenues of $40.2 Million

ARLINGTON, Va., Feb. 10, 2017 (GLOBE NEWSWIRE) -- FBR & Co. (NASDAQ: FBRC ) ("FBR" or the “Company"), a leading investment bank serving the middle market, today reported pre-tax income of $5.2 million on revenues of $40.2 million, and a 12.8 percent pre-tax operating margin, for the fourth quarter of 2016.  This compares to a pre-tax loss of $10.0 million on revenues of $23.5 million for the fourth quarter of 2015, and a pre-tax loss of $11.6 million on revenues of $19.3 million for the third quarter of 2016. Net after-tax income for the fourth quarter of 2016 was $5.0 million, or $0.68 per diluted share, compared to a net loss of $4.4 million, or $0.59 per share, for the fourth quarter of 2015, and a net loss of $57.3 million, or $7.88 per share for the third quarter of 2016. 

For the year ended December 31, 2016, the pre-tax operating loss was $27.8 million on revenues of $98.3 million, compared to a pre-tax operating loss of $15.8 million on revenues of $120.4 million for the year ended December 31, 2015. The net after-tax loss for the year ended December 31, 2016 was $66.0 million, or $8.89 per share, compared to a net after-tax loss of $7.5 million, or $0.92 per share for the year ended December 31, 2015. The increase in year-over-year net loss was primarily driven by a $38.3 million tax provision recorded in 2016 related to the establishment of a full valuation reserve against the Company’s deferred tax assets.    

“In the fourth quarter we generated revenue more in line with our historical averages and our results reflected more closely our expected margins and profitability. As capital markets activity picked up in the energy sector we were able to execute a large, sole-managed offering which significantly impacted our results,” said Chairman and Chief Executive Officer, Richard J. Hendrix. “Looking forward, we have an active banking pipeline of engaged transactions and have already generated more banking revenue in first quarter than we did in any of the first three quarters of 2016.”

2016 Composition of Revenues

Investment Banking

Investment banking revenue was $28.6 million for the fourth quarter of 2016, compared to $14.0 million for the fourth quarter of 2015 and $9.2 million for the third quarter of 2016.  During the quarter, FBR completed 21 client engagements representing $1.7 billion in transaction value including one large sole-managed equity private placement. This compares to 16 engagements representing $1.8 billion in transaction value for the same period in 2015, and 13 engagements representing $1.6 billion in transaction value in the third quarter of 2016.   

For the year ended December 31, 2016, investment banking revenue was $50.5 million compared to $71.1 million in 2015. Full year revenues were generated by 63 client engagements representing a total of $5.9 billion in transaction volume, compared to 51 client engagements representing $9.3 billion in transaction volume in 2015. The decline in year-over-year revenue primarily reflects the completion of fewer sole-managed private transactions – one in 2016, compared to four in 2015, related to the contraction in the small cap IPO market as activity declined by over 35 percent from 2015 levels.

Institutional Brokerage

Net revenue generated in institutional brokerage was $11.3 million for the fourth quarter of 2016, compared to $12.2 million for the fourth quarter of 2015 and $10.4 million for the third quarter of 2016. For the year ended December 31, 2016, net revenues generated in institutional brokerage were $47.7 million in 2016, compared to $53.5 million in 2015. This decrease in 2016 resulted from lower industry-wide cash equities trading volumes. 

2016 Expenses

Non-compensation fixed expenses for the fourth quarter of 2016 totaled $9.1 million, compared to $11.7 million for the fourth quarter of 2015 and $9.2 million for the third quarter of 2016, excluding the one-time goodwill impairment charge. For the year ended December 31, 2016, non-compensation fixed expenses totaled $38.4 million, excluding the goodwill impairment charge, down eight percent compared to $41.9 million in 2015.

Compensation and benefits expense for the fourth quarter of 2016 was $22.1 million, which resulted in a more normalized compensation-to-net revenue ratio of 55 percent. This compares to $17.6 million for the fourth quarter of 2015 and $16.5 million for the third quarter of 2016.  For the year ended December 31, 2016, compensation and benefits expense totaled $73.3 million, compared to $77.5 million in 2015. 

Employees

At December 31, 2016, the Company had 259 full-time employees, compared to 273 at September 30, 2016 and 303 at December 31, 2015.

Share Repurchase Activity

For the year ended December 31, 2016, the Company repurchased approximately 756 thousand shares of its common stock in the open market at an aggregate price of $13.1 million, or an average of $17.34 per share. No shares were repurchased in the open market during the fourth quarter of 2016. As of December 31, 2016, the Company had 722 thousand shares remaining under its repurchase authorization.

Additionally, for the year ending December 31, 2016, FBR acquired 548 thousand shares outside of the share repurchase program as a result of netting of shares for tax withholding purposes on employee share vesting for $9.3 million. 

Quarterly Dividend

The Board of Directors declared a quarterly cash dividend of $0.20 per common share to be paid March 3, 2017 to all shareholders of record as of the close of business on February 20, 2017.

Balance Sheet

As of December 31, 2016, FBR continued to maintain an unlevered and highly liquid balance sheet, with cash and cash equivalents of $75.0 million, compared to $70.1 million as of December 31, 2015. Over the last twelve months, FBR has significantly reduced its investment positions in order to fund repurchase activity and add to overall firm liquidity.  The Company ended 2016 with net investment positions of approximately $27 million, down from $87 million at the end of 2015.

Shareholders’ equity as of December 31, 2016 was $117 million, and tangible book value per share was $15.51, based on 7.28 million shares outstanding, compared to shareholders’ equity of $211 million and tangible book value per share of $27.83 as of December 31, 2015. The decline in shareholders’ equity and tangible book value per share resulted from the combination of the operating loss for the year and the recording of a full valuation allowance against the Company’s deferred tax assets in 2016.

Conference Call

Investors wishing to listen to the earnings call at 9:00 A.M. U.S. EST, Friday, February 10, 2017, may do so via the Web or conference call at:

Webcast link:   http://edge.media-server.com/m/p/8oq5i6qw  

Conference call dial-in number (domestic, toll-free):  855.425.4204

Conference call dial-in number (international):  484.756.4245

Access code:  47777301

About FBR

FBR & Co. (Nasdaq: FBRC ) provides investment banking, merger and acquisition advisory, institutional brokerage, and research services through its subsidiaries FBR Capital Markets & Co. and MLV & Co. FBR focuses capital and financial expertise on the following industry sectors: consumer; energy & natural resources; financial institutions; healthcare; insurance; industrials; real estate; and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices throughout the United States. For more information, please visit www.fbr.com .

Statements in this release concerning future performance, developments, events, market forecasts, revenues, expenses, earnings, run rates and any other guidance on present or future periods constitute forward-looking statements. These forward-looking statements are subject to a number of factors, risks and uncertainties that might cause actual results to differ materially from stated expectations or current circumstances. These factors include, but are not limited to, the effect of demand for public and private securities offerings, activity in the secondary securities markets, interest rates, the risks associated with merchant banking investments, the realization of gains and losses on principal investments, available technologies, competition for business and personnel, and general economic, political and market conditions. Financial results may fluctuate substantially from quarter-to-quarter depending on the number, size and timing of completed transactions. We have experienced, and expect to experience in the future, significant variations in our revenues and results of operations and, as a result, are unlikely to achieve steady and predictable earnings on a quarterly basis. For a discussion of these and other risks and important factors that could affect FBR's future results and financial condition, see "Risk Factors" in Part I, Item 1A and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015; and other items throughout the Company's Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Financial data follows.

                     
FBR & CO.                    
CONSOLIDATED STATEMENTS OF OPERATIONS                
(Dollars in thousands, except per share amounts)                  
(Unaudited)                    
                     
      Quarter Ended     Year Ended
      December 31,     December 31,
                     
        2016     2015         2016       2015  
REVENUES:                  
Investment banking:                  
Capital raising   $   24,661   $   9,820       $ 43,092     $ 61,508  
Advisory       3,942       4,141         7,453       9,583  
Institutional brokerage       9,373       9,533         39,213       45,442  
Interest         6,051       8,387         29,977       31,774  
Net investment income (loss)       298       (2,373 )       (557 )     5,433  
Dividends & other       25       1,061         527       1,692  
Total revenues       44,350       30,569         119,705       155,432  
Interest expense       4,140       7,105         21,388       35,037  
Revenues, net of interest expense       40,210       23,464         98,317       120,395  
                     
NON-INTEREST EXPENSES:                  
Compensation and benefits       22,116       17,628         73,313       77,463  
Occupancy and equipment     2,809       3,350         12,318       12,680  
Professional services       2,916       3,640         9,798       13,287  
Communications     2,112       2,746         9,119       10,865  
Business development       2,392       2,995         8,382       9,819  
Clearing and brokerage fees     1,233       1,331         5,180       5,328  
Impairment of goodwill   -     -         1,259       -  
Other operating expenses     1,476       1,778         6,700       6,711  
Total non-interest expenses       35,054       33,468         126,069       136,153  
                     
Income (loss) before income taxes       5,156       (10,004 )       (27,752 )     (15,758 )
                     
Income tax provision (benefit)       167       (5,594 )       38,252       (8,297 )
                     
Net income (loss)   $   4,989   $   (4,410 )     $ (66,004 )   $ (7,461 )
                     
Basic income (loss) per share   $   0.69   $   (0.59 )     $ (8.89 )   $ (0.92 )
Diluted income (loss) per share   $   0.68   $   (0.59 )     $ (8.89 )   $ (0.92 )
                     
Weighted average shares  - basic     7,275     7,482         7,428       8,069  
Weighted average shares  - diluted     7,311     7,482         7,428       8,069  
Cash dividends per common share   $   0.20   $   0.20       $ 0.80     $ 0.40  
             
  FBR & CO.        
  CONSOLIDATED BALANCE SHEETS        
  (Dollars in thousands, except per share amounts)      
  (Unaudited)        
             
        December 31,   December 31,
  ASSETS       2016       2015  
             
  Cash and cash equivalents   $   75,019     $   70,067  
  Receivables:        
  Securities borrowed       897,343         685,037  
  Due from brokers, dealers and clearing organizations     4,828         5,513  
  Customers       2,805         1,429  
  Other         4,297         5,895  
  Financial instruments owned, at fair value     32,401         94,923  
  Other investments, at cost       -         6,539  
  Goodwill and intangibles       4,490         6,273  
  Furniture, equipment, software and leasehold improvements, net     12,624         15,071  
  Deferred tax assets, net of valuation allowance     -         37,497  
  Prepaid expenses and other assets     4,134         5,172  
    Total assets   $   1,037,941     $   933,416  
             
             
  LIABILITIES AND SHAREHOLDERS’ EQUITY      
             
  Liabilities:        
  Securities loaned   $   892,309     $   687,443  
  Financial instruments sold, not yet purchased, at fair value     -         1,934  
  Accrued compensation and benefits     12,291         13,325  
  Accounts payable, accrued expenses and other liabilities     15,923         19,947  
    Total liabilities       920,523         722,649  
             
             
             
  Shareholders' equity:        
  Common stock       7         7  
  Additional paid-in capital       252,311         259,011  
  Restricted stock units       14,771         35,929  
  Accumulated deficit       (149,671 )       (84,180 )
    Total shareholders' equity      117,418         210,767  
             
    Total liabilities and shareholders' equity $   1,037,941     $   933,416  
             
             
  Book Value per Share   $ 16.13     $ 28.69  
             
  Tangible Book Value per Share $ 15.51     $ 27.83  
             
  Shares Outstanding (in thousands)   7,279       7,347  
FBR & CO.                        
Financial & Statistical Supplement - Operating Results                      
(Dollars in thousands)                      
(Unaudited)                      
                       
    Q-4 16   Q-3 16   Q-2 16   Q-1 16   Q-4 15  
Revenues, net of interest expense $   40,210     $   19,320     $   20,887     $   17,900     $   23,464    
                       
Expenses:                      
Variable       14,008         6,964         6,728         6,436         7,467    
Fixed       21,046         23,989         23,349         23,549         26,001    
                       
Income (loss) before income taxes     5,156         (11,633 )       (9,190 )       (12,085 )       (10,004 )  
Income tax provision (benefit)     167         45,698         (982 )       (6,631 )       (5,594 )  
                       
Net income (loss)   $   4,989     $   (57,331 )   $   (8,208 )   $   (5,454 )   $   (4,410 )  
                       
Return on equity (trailing twelve months)   -40.2 %     -44.8 %     -10.6 %     -4.8 %     -3.2 %  
                       
Fixed expenses   $   21,046     $   23,989     $   23,349     $   23,549     $   26,001    
Less:  Non-cash expenses 1     573         1,510         582       -         1,701    
Core fixed costs 2   $   20,473     $   22,479     $   22,767     $   23,549     $   24,300    
                       
                       
Statistical Data                      
Revenues per employee (annualized) $   621     $   283     $   288     $   249     $   310    
                       
Employee count       259         273         290         287         303    
                       
                       
                       
1  Non-cash expenses include compensation costs associated with stock-based awards, amortization of intangibles and impairment of goodwill.
                       
2   Core fixed costs is a non-GAAP measurement used by management to analyze and assess the Company’s fixed operating  
  costs. Management believes that this non-GAAP measurement assists investors in understanding the impact of the items noted in
  footnote 1 on the performance of the Company.                  
                       
  A limitation of utilizing this non-GAAP measure is that the GAAP accounting effects of these items do in fact reflect the  
  underlying financial results of the Company and these effects should not be ignored in evaluating and analyzing the  
  Company's financial results. Therefore, management believes fixed expenses on a GAAP basis and core fixed costs  
  on a non-GAAP basis should be considered together.                  
                       

Contacts: Media and Investors: Linda E. Eddy at 703.312.9715 or leddy@fbr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading